Efficacy of Generic Imatinib After Switching from Original in Treatment of Patients with Chronic Myeloid Leukemia in the Republic of North Macedonia - A Single-Center Experience

被引：0
|
作者：
Dukovski, Dushko [1 ]
Trajkova, Sanja [1 ]
Stojanovska, Simona [1 ]
Ridova, Nevenka [1 ]
Panovska-Stavridis, Irina [1 ]
机构：
[1] Clin Hematol, Skopje, North Macedonia
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2020年 / 20卷
关键词：
CML; imatinib; selective tyrosine kinase inhibitor (TKI); chronic myeloid leukemia;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CML-104
引用
收藏
页码：S232 / S232
页数：1
相关论文
共 50 条
  • [31] TREATMENT OF PHILADELPHIA - POSITIVE CHRONIC MYELOID LEUKEMIA WITH IMATINIB: ONE CENTER EXPERIENCE
    Danaila, C.
    Dascalescu, A.
    Bujoran, C.
    Dorohoi, G.
    Gorduza, E. V.
    Ivanov, I.
    Burcoveanu, C.
    Hanganu-Turtureanu, E.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 579 - 579
  • [32] EVALUATION OF THE EFFECTIVENESS AND TOXICITY OF GLIVEC AND GENERIC IMATINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA. REVIEW IN A SINGLE CENTER
    Vilaseca, Creus Xavier
    Ramila, Herrero Maria Elena
    Piedra, Sanchez Jordi
    Soriano, Gutierrez Laura
    Segura, de laTorre Laura
    Martinez, de Sola Montserrat
    Piernas, Pontanillas Sonia
    Gomez, Nunez Marta
    Soler, Campos
    Juan, Alfonso
    Roig, Martinez Immaculada
    HAEMATOLOGICA, 2020, 105 : 247 - 247
  • [33] Comparable efficacy and safety of generic and branded imatinib for patients with chronic myeloid leukemia in China
    Cheng, Fang
    Wu, Di
    Cui, Zheng
    Li, Qiang
    Li, Weiming
    Zhang, Yu
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2024, 15
  • [34] Evaluation of the Safety of Imatinib Mesylate in 200 Iraqi Patients with Chronic Myeloid Leukemia in the Chronic Phase: Single-Center Study
    Matti, Bassam Francis
    Naji, Alaadin Sahham
    Alwan, Alaa Fadhil
    TURKISH JOURNAL OF HEMATOLOGY, 2013, 30 (04) : 387 - 393
  • [35] Prior exposure to imatinib does not impact outcome of allogeneic hematopoietic transplantation for chronic myeloid leukemia patients: a single-center experience in china
    Shen, Kefeng
    Liu, Qifa
    Sun, Jing
    Jiang, Qianli
    Ye, Yanyan
    Huang, Hao
    Meng, Fanyi
    Zhou, Yongjun
    Yang, Mo
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (02): : 2495 - 2505
  • [36] ANALYSIS OF GENERIC IMATINIB EFFICACY IN CHRONIC MYELOID LEUKEMIA TREATMENT: MORE THAN FOUR YEARS OF EXPERIENCE IN SOUTHERN SERBIA
    Cojbasic, I.
    Golubovic, L. Macukanovic
    Vucic, M.
    Tijanic, I.
    HAEMATOLOGICA, 2017, 102 : 731 - 731
  • [37] Dasatinib (Sprycel®) in patients with philadelphia chromosome-positive acute lymphoblastic leukemia or lymphoid blast phase chronic myeloid leukemia after imatinib failure:: A single-center experience
    Piccaluga, P. P.
    Rosti, G.
    Rondoni, M.
    Amabile, M.
    Bosi, C.
    Castagnetti, F.
    Iacobucci, L.
    Laterza, C.
    Palandri, F.
    Paolini, S.
    Soverini, S.
    Verlicchi, L.
    Visani, G.
    Baccarani, M.
    Martinelli, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 181 - 182
  • [38] Chronic Myeloid Leukemia in Adolescents and Young Adults Treated with Generic Form of Imatinib in Resource Limited Setting: A Single Center Experience from Myanmar
    Han, Yin Nwe
    Gyi, Aye Aye
    Htut, Khin Thida
    BLOOD, 2018, 132
  • [39] Good adherence to imatinib therapy among patients with chronic myeloid leukemia-a single-center observational study
    Jonsson, Sofia
    Olsson, Bob
    Soderberg, Jenny
    Wadenvik, Hans
    ANNALS OF HEMATOLOGY, 2012, 91 (05) : 679 - 685
  • [40] Erratum to: Good adherence to imatinib therapy among patients with chronic myeloid leukemia—a single-center observational study
    Sofia Jönsson
    Bob Olsson
    Jenny Söderberg
    Hans Wadenvik
    Annals of Hematology, 2017, 96 : 1419 - 1419
12345